Cidara Therapeutics initiated with an Outperform at Citizens JMP
Citizens JMP analyst Roy Buchanan initiated coverage of Cidara Therapeutics (CDTX) with an Outperform rating and $46 price target Potential ...
Business Insider27d
AN2 Therapeutics, Inc. (ANTX) Gets a Buy from JMP Securities
JMP Securities analyst Roy Buchanan reiterated a Buy rating on AN2 Therapeutics, Inc. (ANTX – Research Report) today and set a price target of $5.00. The company’s shares closed yesterday at ...